Idexx Laboratories SEC filings, summarized
We read every Idexx Laboratories 8-K filing and insider trade the night it hits SEC EDGAR, and turn it into a two-minute plain-English summary.
Track IDXX in your inbox
Add Idexx Laboratories to your watchlist — free, every morning.
Recent filings
IDEXX ($IDXX) filed an 8‑K (Item 9.01) disclosing a Separation Agreement (Exhibit 10.1) between Nimrata…
IDEXX ($IDXX) filed an 8‑K (Item 9.01) disclosing a Separation Agreement (Exhibit 10.1) between Nimrata Hunt, PhD and IDEXX dated March 24, 2026. Investors…
IDEXX ($IDXX) and Nimrata Hunt, EVP Global Strategy & Commercial, agreed she’ll cease her role Apr 13,…
IDEXX ($IDXX) and Nimrata Hunt, EVP Global Strategy & Commercial, agreed she’ll cease her role Apr 13, 2026 and serve as advisor through Jul 13, 2026.…
IDEXX ($IDXX): Director M.
IDEXX ($IDXX): Director M. Anne Szostak notified the company on Feb 13, 2026 she will retire from the Board effective immediately after the 2026 Annual…
IDEXX furnished a press release titled “IDEXX Laboratories Announces Fourth Quarter and Full Year 2025…
IDEXX furnished a press release titled “IDEXX Laboratories Announces Fourth Quarter and Full Year 2025 Results” (Exhibit 99.1) dated Feb 2, 2026 —…
IDEXX ($IDXX) announced financial results for the quarter and year ended Dec 31, 2025 on Feb 2, 2026.
IDEXX ($IDXX) announced financial results for the quarter and year ended Dec 31, 2025 on Feb 2, 2026. Press release is furnished as Exhibit 99.1 to the Form…
IDEXX filed Item 9.01 exhibits: a Letter Agreement and an Amended & Restated Change‑in‑Control Agreement…
IDEXX filed Item 9.01 exhibits: a Letter Agreement and an Amended & Restated Change‑in‑Control Agreement with Michael (Mike) Erickson, PhD, dated Jan 12,…
IDEXX LABORATORIES filed a Form 8‑K (Item 7.01) on Jan 13, 2026 furnishing a press release as Exhibit 99.1…
IDEXX LABORATORIES filed a Form 8‑K (Item 7.01) on Jan 13, 2026 furnishing a press release as Exhibit 99.1 under Regulation FD. Press release dated Jan 13,…